CHOD/BVAM regimen plus radiotherapy in patients with primary CNS non-Hodgkin's lymphoma.

@article{Bessell2001CHODBVAMRP,
  title={CHOD/BVAM regimen plus radiotherapy in patients with primary CNS non-Hodgkin's lymphoma.},
  author={Eric M. Bessell and Francesc Graus and Armando L{\'o}pez-Guillermo and Salvador Vill{\'a} and Eug{\`e}nia Verger and Josep D az Jordi Petit and Ian Holland and Patrick D Byrne},
  journal={International journal of radiation oncology, biology, physics},
  year={2001},
  volume={50 2},
  pages={457-64}
}
PURPOSE To assess the efficacy and toxicity, including long-term neurotoxicity, of combined therapy with the CHOD/BVAM regimen given before cranial radiotherapy in the treatment of primary CNS lymphoma (PCNSL). METHODS AND MATERIALS Thirty-one consecutive patients with PCNSL were treated with one cycle of cyclophosphamide, doxorubicin, vincristine, and dexamethasone (CHOD) and two of carmustine (BCNU), vincristine, cytosine arabinoside, and methotrexate (BVAM), followed by cranial… CONTINUE READING